Company Data

Mineralys Therapeutics Inc.

Ticker
MLYS
Current Price
$15.48 1.71%
Market Cap
$1.0B
Price Target
Refer to Report
Volume
942.5K
52wk Range
$8.241 - $18.38
Advanced Market Data

Overview

Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and associated cardiovascular diseases. It clinical-stage product candidate is lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase inhibitor for the treatment of patients with uncontrolled or resistant hypertension. The company was incorporated in 2019 and is headquartered in Radnor, Pennsylvania.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy